UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reflections on the Boston Marathon from a Breast Cancer Oncologist (or, Why I Just Don't Quit)

The oncologist (Dayton, Ohio), 2018-12, Vol.23 (12), p.1548-1548

Comander, Amy H.

2018

Volltextzugriff (PDF)

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

Journal of clinical oncology, 2021-02, Vol.39 (6), p.685-693

2021

Volltextzugriff (PDF)

Remember Your Why: An Oncologist's Reflections on Running During the COVID‐19 Pandemic

The oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.348-349

Comander, Amy

2021

Volltextzugriff (PDF)

Testing psychosocial mediators of a mind–body resiliency intervention for cancer survivors

Supportive care in cancer, 2022-07, Vol.30 (7), p.5911-5919

2022

Volltextzugriff (PDF)

Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)

Breast cancer research and treatment, 2022-06, Vol.193 (3), p.579-587

2022

Volltextzugriff (PDF)

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

Breast cancer research : BCR, 2010-01, Vol.12 (1), p.R12-R12, Article R12

2010

Volltextzugriff (PDF)

Do cancer curvivors and metavivors have distinct needs for stress management intervention? Retrospective analysis of a mind–body survivorship program

Supportive care in cancer, 2023-10, Vol.31 (10), p.616-616, Article 616

2023

Volltextzugriff (PDF)

Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2‐Hydroxyglutarate

The oncologist (Dayton, Ohio), 2014-06, Vol.19 (6), p.602-607

2014

Volltextzugriff (PDF)

Comparing Outcomes of a Digital Commercial Weight Loss Program in Adult Cancer Survivors and Matched Controls with Overweight or Obesity: Retrospective Analysis

Nutrients, 2021-08, Vol.13 (9), p.2908

2021

Volltextzugriff (PDF)

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221119370-17588359221119370

2022

Volltextzugriff (PDF)

PAVING the Path to Wellness for Breast Cancer Survivors: Lifestyle Medicine Education and Group Interventions

American journal of lifestyle medicine, 2021-05, Vol.15 (3), p.242-248

2021

Volltextzugriff (PDF)

0421 Synchronous Virtual Cognitive Behavioral Therapy for Insomnia: Preliminary Results of Sleep Pattern Changes among Cancer Survivors

Sleep (New York, N.Y.), 2023-05, Vol.46 (Supplement_1), p.A186-A187

2023

Volltextzugriff (PDF)

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

Journal of clinical oncology, 2022-01, Vol.40 (3), p.307-309

2022

Volltextzugriff (PDF)

PAVING the path to wellness: Lifestyle medicine to improve outcomes in breast cancer survivors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24053-e24053

2023

Volltextzugriff (PDF)

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update

Journal of clinical oncology, 2024-06, Vol.42 (18), p.2233

2024

Volltextzugriff (PDF)

Restoring Well-Being for Physicians Through Lifestyle Medicine

American journal of lifestyle medicine, 2024-03, Vol.18 (2), p.260-268

2024

Volltextzugriff (PDF)

Association of Sarcopenia With Toxicity-Related Discontinuation of Adjuvant Endocrine Therapy in Women With Early-Stage Hormone Receptor-Positive Breast Cancer

International journal of radiation oncology, biology, physics, 2024-01, Vol.118 (1), p.94-103

2024

Volltextzugriff (PDF)

Abstract OT-03-06: Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer (NeoSTAR)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-03-06-OT-03-06

2021

Volltextzugriff (PDF)

Abstract P1-14-02: Phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor, ribociclib, for localized ER+/HER2- breast cancer (LEADER, part 1)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-14-02

2022

Volltextzugriff (PDF)

Abstract PD5-11: Pilot study to assess prolonged nightly fasting in breast cancer survivors (LONGFAST)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD5-11-PD5-11

2022

Volltextzugriff (PDF)

The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors

Cancer, 2022-04, Vol.128 (7), p.1532-1544

2022

Volltextzugriff (PDF)

Living Your Best Life: Lifestyle Medicine for All Women

American Journal of Lifestyle Medicine, 2022-09, Vol.16 (5), p.577-588

2022

Volltextzugriff (PDF)

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers

Cancer, 2011-07, Vol.117 (14), p.3093-3100

2011

Volltextzugriff (PDF)

Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.512-512

2022

Volltextzugriff (PDF)

Breast Cancer: A Lifestyle Medicine Approach

American Journal of Lifestyle Medicine, 2020-09, Vol.14 (5), p.483-494

2020

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)
Buchkapitel
(3)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(16)
Oncology
(16)
Female
(11)
Breast Cancer
(10)
Cancer
(8)
Adult
(7)
Aged
(7)
Middle Aged
(7)
Breast Neoplasms - Drug Therapy
(6)
Breast Neoplasms - Pathology
(5)
Medicine
(5)
Medicine & Public Health
(5)
Public, Environmental & Occupational Health
(5)
Survivorship
(5)
Cancer Survivors
(4)
Cancer Therapies
(4)
Exercise
(4)
Retrospective Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reflections on the Boston Marathon from a Breast Cancer Oncologist (or, Why I Just Don't Quit)

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

Remember Your Why: An Oncologist's Reflections on Running During the COVID‐19 Pandemic

Testing psychosocial mediators of a mind–body resiliency intervention for cancer survivors

Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

Do cancer curvivors and metavivors have distinct needs for stress management intervention? Retrospective analysis of a mind–body survivorship program

Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2‐Hydroxyglutarate

Comparing Outcomes of a Digital Commercial Weight Loss Program in Adult Cancer Survivors and Matched Controls with Overweight or Obesity: Retrospective Analysis

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

PAVING the Path to Wellness for Breast Cancer Survivors: Lifestyle Medicine Education and Group Interventions

0421 Synchronous Virtual Cognitive Behavioral Therapy for Insomnia: Preliminary Results of Sleep Pattern Changes among Cancer Survivors

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

PAVING the path to wellness: Lifestyle medicine to improve outcomes in breast cancer survivors

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update

Restoring Well-Being for Physicians Through Lifestyle Medicine

Association of Sarcopenia With Toxicity-Related Discontinuation of Adjuvant Endocrine Therapy in Women With Early-Stage Hormone Receptor-Positive Breast Cancer

Abstract OT-03-06: Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer (NeoSTAR)

Abstract P1-14-02: Phase II study of adjuvant endocrine therapy with CDK 4/6 inhibitor, ribociclib, for localized ER+/HER2- breast cancer (LEADER, part 1)

Abstract PD5-11: Pilot study to assess prolonged nightly fasting in breast cancer survivors (LONGFAST)

The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors

Living Your Best Life: Lifestyle Medicine for All Women

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers

Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial

Breast Cancer: A Lifestyle Medicine Approach

Suchergebnisse filtern